investors.medicalmarijuanainc.comInvestor Home - Medical Marijuana, Inc - Investors

More: MJNA HOME CANNABIS NEWS SHOP CONTACT Dashboard Reports & Disclosure Financial Results Shareholder Shareholder Information Shareholder Rewards News Media Coverage Press Releases Follow Follow Follow Follow Follow Follow Dashboard Reports & Disclosure Financial Results Shareholder Shareholder Information Shareholder Rewards News Media Coverage Press Releases INVESTORS INVESTOR RELATIONS CONTACT 1 (858) 283-4016 [email protected]We are a company of firsts® . Medical Marijuana, Inc. ( MJNA ) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds® ; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc . and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC . Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.  100+ SKUs Across 12 Brands  40+ COUNTRY DISTRIBUTION Health Authority Approval in Mexico and Brazil  $46.9M 2020 REVENUE Margins Over 75%  6 COMPANIES IN PORTFOLIO Serving Consumer, B2B, Pharmaceutical Markets OUR HISTORY What Makes Us A Company of Firsts® MOREGet to Know Our Team and Portfolio STAY UP-TO-DATE WITH MJNA PRESS RELEASES Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point Jan 24, 2023 New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant... Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil Aug 11, 2022 SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE)via NewMediaWire – Medical Marijuana, Inc. (OTC:... Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Exponential Growth; Receives Validation From Medical Community Apr 21, 2022 SAN DIEGO, CA, April 21, 2022 (GLOBE NEWSWIRE)via NewMediaWireMedical Marijuana,... See All MEDIA COVERAGE Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology Nov 29, 2022 Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information... Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President Oct 4, 2022 SAN DIEGO, CA, Oct. 04, 2022 (GLOBE NEWSWIRE)via NewMediaWire – Medical Marijuana, Inc. (OTC:... Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in May 2022 Jun 14, 2022 SAN DIEGO, CA, June 14, 2022 (GLOBE NEWSWIRE)via NewMediaWire – Medical Marijuana, Inc. (OTC:... See All STOCK INFO LAST 0.0265 Change -0.0005 OPEN 0.0200 Change % 1.85% HIGH 0.0287 52 Week Range 0.01-0.222 LOWW 0.0200 Day Range 0.0200-0.0287 VOLUME 15119948 Market Cap (real-time) N/A Last Updated: 08-20-2021 (US/Eastern) Subscribe for Company Updates * indicates required First Name Last Name Email Address * Follow us on social networks Follow Follow Follow Follow Follow Home Company Education Careers Shop This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. Food and Drug Administration (FDA) Disclosure These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users. The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site. * Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant. Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products. © 2021 Medical Marijuana, Inc. All Rights...